Foresta Group Holdings has secured a key Japanese patent acceptance for its proprietary pine chemical extraction technology, reinforcing its global intellectual property portfolio and supporting its commercial ambitions.
Anatara Lifesciences has been granted a key Australian patent for its GaRP gastrointestinal health product, reinforcing its intellectual property portfolio ahead of pivotal clinical trial results expected in March 2025.